| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Indivior Pharmaceuticals, Inc. (INDV) has 7 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. INDV is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 20.6K | $785.7K | - | |
| Dir | 20.6K | $782.9K | - | |
| Dir | 20.4K | $774.5K | - | |
| Dir | 9.5K | $362.5K | - | |
| Dir | 7.6K | $288.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Ryan Barbara | Director | Buy | 31 | $32.56 | $1,009.36 | +0.5% | - | - | |
| Mar 6, 2026 | Kingsley Stuart A | Director | Buy | 940 | $31.87 | $29,953.10 | +20.2% | - | - | |
| Jan 5, 2026 | Ryan Barbara | Director | Buy | 775 | $35.39 | $27,429.27 | +65.2% | -16.1% | - | |
| Jan 5, 2026 | Humphreys Keith | Director | Buy | 775 | $35.39 | $27,429.27 | +15.4% | -16.1% | - | |
| Jan 5, 2026 | Stejbach Mark | Director | Buy | 775 | $35.39 | $27,429.27 | +4.8% | -16.1% | - | |
| Jan 5, 2026 | Wheadon David E. | Director | Buy | 1,771 | $35.39 | $62,680.29 | +14.0% | -16.1% | - | |
| Jan 5, 2026 | Ninivaggi Daniel A | Director | Buy | 775 | $35.39 | $27,429.27 | +4.8% | -16.1% | - |